top of page

The first French biotech approved by the ANSM to start its R&D process on cannabis production for pharmaceutical purposes

Medical cannabis - from seed to purified pharmaceutical grade active ingredients

Capture d’écran 2021-11-17 à 00.06.19.png
Biologiste des plantes

About us

 

Overseed is a French Biotech which combines leading expertise in genetics, agronomy, organic chemistry and pharma with the ambition to have an expert knowledge on the production of therapeutic cannabis. Overseed develops production and research on cannabinoids for medical applications. We produce dried flowers, full spectrum extracts and purified pharmaceutical grade active ingredients for laboratories.

​

​

Overseed's research and experimentation will answer patients and the health industry expectations to guarantee production sovereignty, proximity of collaborations and certified quality of cultivated products, in direct connection with medical and scientific studies.

​

À propos

Our team

Hugues.webp

Hugues Péribère

Founder & CEO

Agronomy engineer

1608365674377_edited.jpg

Maurice Sofeir

Scientific advisor

Former Worldwide Director of Scientific Development, Sanofi

IMG_4463.jpg

Houssein Monder

Head of R&D

PhD Ecophysiology and Adaptation

serge calet.jpeg

Serge Calet

Scientific advisor

PhD. Organic chemistry

IMG_4461.jpg

Laurent Walzer

Head of Quality Regulatory Affairs

Pharmacist

JEROME 2_edited.jpg

Jérome Péribère

Strategic advisor

Ex CEO, Sealed Air

IMG_4464.jpg

Arnaud Lanz

Head of Production

Agronomy engineer

LAURE.png

Laure de Laporterie

Financial advisor

Corporate Finance

Equpe

Our partners

image.png
image.png
image.png

Overseed is member of

*Founding member

Services et Produits

Our products & services 

Products

Dried cannabis flowers 

Full-spectrum extracts

Purified active ingredients

image.png

*In the process of being certified

Co-R&D

As the first French player with a R&D license for the cultivation of medical cannabis, Overseed offers R&D services on production, stabilization and characterization of pharmaceutical grade cannabinoids, for industrial purposes.

​

Ancre 1

Contact

+33 06 03 23 13 86

  • LinkedIn
bottom of page